Lipid metabolism, apoptosis and cancer therapy

International Journal of Molecular Sciences

Volumn 16, Issue 1, 2015, Pages 924-949

  Huang, Chunfa ^a   Freter, Carl ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Bioactive lipid molecule; Cancer therapy; Cell signaling; Lipid metabolism

Indexed keywords

APOLIPOPROTEIN; CAVEOLIN; CERAMIDASE; CERAMIDE; CHOLESTEROL; CONSTITUTIVE ANDROSTANE RECEPTOR; FARNESOID X RECEPTOR; FAS LIGAND; FATTY ACID; G PROTEIN COUPLED RECEPTOR; INTEGRIN; ION CHANNEL; MAMMALIAN TARGET OF RAPAMYCIN; MICRORNA; ORPHAN NUCLEAR RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PHOSPHATIDIC ACID; PHOSPHOLIPASE A2; PHOSPHOLIPASE C; PREGNANE X RECEPTOR; PROTEIN BAX; PROTEIN P53; PROTEIN TYROSINE KINASE; PUMA PROTEIN; SPHINGOMYELIN PHOSPHODIESTERASE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNINDEXED DRUG; VITAMIN D RECEPTOR; ANTINEOPLASTIC AGENT; FATTY ACID SYNTHASE; GLYCEROPHOSPHOLIPID; SPHINGOLIPID;

APOPTOSIS; CALCIUM CELL LEVEL; CANCER THERAPY; CELL DEATH; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; HUMAN; INFLAMMATION; LIPID METABOLISM; MEMBRANE PERMEABILITY; OXIDATION; OXIDATIVE STRESS; PH; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION; DRUG EFFECTS; METABOLISM; NEOPLASMS; PATHOLOGY;

ANTINEOPLASTIC AGENTS; APOPTOSIS; FATTY ACID SYNTHASES; GLYCEROPHOSPHOLIPIDS; HUMANS; LIPID METABOLISM; MICRORNAS; NEOPLASMS; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; SPHINGOLIPIDS;

EID: 84920288424     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms16010924     Document Type: Review

References (173)

1. Vance, J.E.; Vance, D. Biochemistry of Lipids, Lipoproteins and Membranes, 5th ed.; Elsevier: Amsterdam, The Netherlands, 2008.
2. Prasad, S.K. Biochemistry of Lipids; Discovery Publishing House: New Delhi, DEL, India, 2010.
3. Mattes, R.D. Fat taste and lipid metabolism in humans. Physiol. Behav. 2005, 86, 691-697.
4. Hannun, Y.A.; Obeid, L.M. Principles of bioactive lipid signalling: Lessons from sphingolipids. Nat. Rev. Mol. Cell Biol. 2008, 9, 139-150.
5. Zechner, R.; Zimmermann, R.; Eichmann, T.O.; Kohlwein, S.D.; Haemmerle, G.; Lass, A.; Madeo, F. Fat signals-Lipases and lipolysis in lipid metabolism and signaling. Cell Metab. 2012, 15, 279-291.
6. Krycer, J.R.; Sharpe, L.J.; Luu, W.; Brown, A.J. The Akt-SREBP nexus: Cell signaling meets lipid metabolism. Trends Endocrinol. Metab. 2010, 21, 268-276.
7. Santos, C.R.; Schulze, A. Lipid metabolism in cancer. FEBS J. 2012, 279, 2610-2623.
8. Fahy, E.; Subramaniam, S.; Murphy, R.; Nishijima, M.; Raetz, C.; Shimizu, T.; Spener, F.; van Meer, G.; Wakelam, M.; Dennis, E.A.; et al. Update of the LIPID MAPS comprehensive classification system for lipids. J. Lipid Res. 2009, 50, S9-S14.
9. Petho, G.; Reeh, P.W. Sensory and signaling mechanisms of bradykinin, eicosanoids, platelet-activating factor, and nitric oxide in peripheral nociceptors. Physiol. Rev. 2012, 92, 1699-1775.
10. Rosca, M.G.; Vazquez, E.J.; Chen, Q.; Kerner, J.; Kern, T.S.; Hoppel, C.L. Oxidation of fatty acids is the source of increased mitochondrial reactive oxygen species production in kidney cortical tubules in early diabetes. Diabetes 2012, 61, 2074-2083.
11. Athenstaedt, K.; Daum, G. The life cycle of neutral lipids: Synthesis, storage and degradation. Cell. Mol. Life Sci. 2006, 63, 1355-1369.
12. Tappia, P.S.; Singal, T. Phospholipid-mediated signaling and heart disease. Subcell. Biochem. 2008, 49, 299-324.
13. Oude Weernink, P.A.; Han, L.; Jakobs, K.H.; Schmidt, M. Dynamic phospholipid signaling by G protein-coupled receptors. Biochim. Biophys. Acta 2007, 1768, 888-900.
14. Gault, C.R.; Obeid, L.M.; Hannun, Y.A. An overview of sphingolipid metabolism: From synthesis to breakdown. Adv. Exp. Med. Biol. 2010, 688, 1-23.
15. Maxfield, F.R.; Tabas, I. Role of cholesterol and lipid organization in disease. Nature 2005, 438, 612-621.
16. Luu, W.; Sharpe, L.J.; Gelissen, I.C.; Brown, A.J. The role of signalling in cellular cholesterol homeostasis. IUBMB Life 2013, 65, 675-684.
17. Gorin, A.; Gabitova, L.; Astsaturov, I. Regulation of cholesterol biosynthesis and cancer signaling. Curr. Opin. Pharmacol. 2012, 12, 710-716.
18. Kuzuyama, T.; Seto, H. Diversity of the biosynthesis of the isoprene units. Nat. Prod. Rep. 2003, 20, 171-183.
19. Raetz, C.R.; Garrett, T.A.; Reynolds, C.M.; Shaw, W.A.; Moore, J.D.; Smith, D.C., Jr.; Ribeiro, A.A.; Murphy, R.C.; Ulevitch, R.J.; Fearns, C.; et al. Kdo2-Lipid A of Escherichia coli, a defined endotoxin that activates macrophages via TLR-4. J. Lipid Res. 2006, 47, 1097-1111.
20. Walsh, C.T. Polyketide and nonribosomal peptide antibiotics: Modularity and versatility. Science 2004, 303, 1805-1810.
21. Minto, R.E.; Blacklock, B.J. Biosynthesis and function of polyacetylenes and allied natural products. Prog. Lipid Res. 2008, 47, 233-306.
22. Thomas, M.J. Physiological aspects of low-density lipoprotein oxidation. Curr. Opin. Lipidol. 2000, 11, 297-301.
23. Lammert, E.; Zee, M. Metabolism of Human Diseases: Organ Physiology and Pathophysiology; Springer: Berlin, Germany, 2014.
24. Wootten, D.; Christopoulos, A.; Sexton, P.M. Emerging paradigms in GPCR allostery: Implications for drug discovery. Nat. Rev. Drug Discov. 2013, 12, 630-644.
25. Wang, C.I.; Lewis, R.J. Emerging opportunities for allosteric modulation of G-protein coupled receptors. Biochem. Pharmacol. 2013, 85, 153-162.
26. Archbold, J.K.; Martin, J.L.; Sweet, M.J. Towards selective lysophospholipid GPCR modulators. Trends Pharmacol. Sci. 2014, 35, 219-226.
27. Ishii, S.; Shimizu, T. Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice. Prog. Lipid Res. 2000, 39, 41-82.
28. Rayasam, G.V.; Tulasi, V.K.; Davis, J.A.; Bansal, V.S. Fatty acid receptors as new therapeutic targets for diabetes. Expert Opin. Ther. Targets. 2007, 11, 661-671.
29. Perona, R. Cell signalling: Growth factors and tyrosine kinase receptors. Clin. Transl. Oncol. 2006, 8, 77-82.
30. Greenhalgh, C.J.; Hilton, D.J. Negative regulation of cytokine signaling. J. Leukoc. Biol. 2001, 70, 348-356.
31. Lebman, D.A.; Spiegel, S. Cross-talk at the crossroads of sphingosine-1-phosphate, growth factors, and cytokine signaling. J. Lipid Res. 2008, 49, 1388-1394.
32. McLaren, J.E.; Michael, D.R.; Ashlin, T.G.; Ramji, D.P. Cytokines, macrophage lipid metabolism and foam cells: Implications for cardiovascular disease therapy. Prog. Lipid Res. 2011, 50, 331-347.
33. Pyne, N.J.; Pyne, S. Receptor tyrosine kinase-G-protein-coupled receptor signalling platforms: Out of the shadow? Trends Pharmacol. Sci. 2011, 32, 443-450.
34. Delcourt, N.; Bockaert, J.; Marin, P. GPCR-jacking: From a new route in RTK signalling to a new concept in GPCR activation. Trends Pharmacol. Sci. 2007, 28, 602-607.
35. Chudakova, D.A.; Zeidan, Y.H.; Wheeler, B.W.; Yu, J.; Novgorodov, S.A.; Kindy, M.S.; Hannun, Y.A.; Gudz, T.I. Integrin-associated Lyn kinase promotes cell survival by suppressing acid sphingomyelinase activity. J. Biol. Chem. 2008, 283, 28806-28816.
36. 2 in bovine pulmonary artery endothelial cells. Am. J. Physiol. 2001, 280, L1049-L1056.
37. Mueller, H.; Stadtmann, A.; van Aken, H.; Hirsch, E.; Wang, D.; Ley, K.; Zarbock, A. Tyrosine kinase Btk regulates E-selectin-mediated integrin activation and neutrophil recruitment by controlling phospholipase C (PLC) γ2 and PI3Kγ pathways. Blood 2010, 115, 3118-3127.
38. Xiong, J.; Balcioglu, H.E.; Danen, E.H. Integrin signaling in control of tumor growth and progression. Int. J. Biochem. Cell Biol. 2013, 45, 1012-1015.
39. Salanueva, I.J.; Cerezo, A.; Guadamillas, M.C.; del Pozo, M.A. Integrin regulation of caveolin function. J. Cell. Mol. Med. 2007, 11, 969-980.
40. Hunte, C.; Richers, S. Lipids and membrane protein structures. Curr. Opin. Struct. Biol. 2008, 18, 406-411.
41. Shipston, M.J. Regulation of large conductance calcium- and voltage-activated potassium (BK) channels by S-palmitoylation. Biochem. Soc. Trans. 2013, 41, 67-71.
42. Kasimova, M.A.; Tarek, M.; Shaytan, A.K.; Shaitan, K.V.; Delemotte, L. Voltage-gated ion channel modulation by lipids: Insights from molecular dynamics simulations. Biochim. Biophys. Acta 2014, 1838, 1322-1331.
43. Minke, B.; Cook, B. TRP channel proteins and signal transduction. Physiol. Rev. 2002, 82, 429-472.
44. 2 to chemical hypoxic injury in rat hepatocytes. FASEB J. 1996, 10, 1319-1325.
45. Marquis, H.; Hager, E.J. pH-regulated activation and release of a bacteria-associated phospholipase C during intracellular infection by Listeria monocytogenes. Mol. Microbiol. 2000, 35, 289-298.
46. Pawliczak, R.; Huang, X.L.; Nanavaty, U.B.; Lawrence, M.; Madara, P.; Shelhamer, J.H. Oxidative stress induces arachidonate release from human lung cells through the epithelial growth factor receptor pathway. Am. J. Respir. Cell Mol. Biol. 2002, 27, 722-731.
47. 2, lipoxygenase, and cyclooxygenase. Mol. Cell. Biochem. 2008, 315, 97-112.
48. Huang, C. Hypertension, mechanical force, and renal disease. Ann. Clin. Exp. Hypertens. 2014, 2, 1009.
49. Chiang, J.Y. Nuclear receptor regulation of lipid metabolism: Potential therapeutics for dyslipidemia, diabetes, and chronic heart and liver diseases. Curr. Opin. Investig. Drugs. 2005, 6, 994-1001.
50. Papacleovoulou, G.; Abu-Hayyeh, S.; Williamson, C. Nuclear receptor-driven alterations in bile acid and lipid metabolic pathways during gestation. Biochim. Biophys. Acta 2011, 1812, 879-887.
51. Goldstein, I.; Rotter, V. Regulation of lipid metabolism by p53-Fighting two villains with one sword. Trends Endocrinol. Metab. 2012, 23, 567-575.
52. Xu. L.; Zhou, L.; Li, P. CIDE proteins and lipid metabolism. Arterioscler. Thromb. Vasc. Biol. 2012, 32, 1094-1098.
53. Boffa, L.C.; Lupton, J.R.; Mariani, M.R. Modulation of colonic epithelial cell proliferation, histone acetylation, and luminal short chain fatty acids by variation of dietary fiber in rats. Cancer Res. 1992, 52, 5906-5912.
54. Matthews, G.M.; Howarth, G.S.; Butler, R.N. Short-chain fatty acid modulation of apoptosis in the Kato III human gastric carcinoma cell line. Cancer Biol. Ther. 2007, 6, 1051-1057.
55. Little, J.L.; Kridel, S.J. Fatty acid synthase activity in tumor cells. Subcell. Biochem. 2008, 49, 169-194.
56. Krycer, J.R.; Brown, A.J. Cholesterol accumulation in prostate cancer: A classic observation from a modern perspective. Biochim. Biophys. Acta 2013, 1835, 219-229.
57. Hilvo, M.; Denkert, C.; Lehtinen, L.; Muller, B.; Brockmoller, S.; Seppanen-Laakso, T.; Budczies, J.; Bucher, E.; Yetukuri, L.; Castillo, S.; et al. Novel theranostic opportunities offered by characterization of altered membrane lipid metabolism in breast cancer progression. Cancer Res. 2011, 71, 3236-3245.
58. Hirsch, H.A.; Iliopoulos, D.; Joshi, A.; Zhang, Y.; Jaeger, S.A.; Bulyk, M.; Tsichlis, P.N.; Liu, S.X.; Struhl, K. A transcriptional signature and common gene networks link cancer with lipid metabolism and diverse human diseases. Cancer Cell 2010, 17, 348-361.
59. Das, S.; Fernandez Matilla, M.; Dass, S.; Buch, M.H.; Rawstron, A.C.; Vital, E.M.; Emery, P. Statins do not influence clinical response and B cell depletion after rituximab treatment in rheumatoid arthritis. Ann. Rheum. Dis. 2013, 72, 463-464.
60. Agarwal, B.; Bhendwal, S.; Halmos, B.; Moss, S.F.; Ramey, W.G.; Holt, P.R. Lovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cells. Clin. Cancer Res. 1999, 5, 2223-2229.
61. Cho, S.J.; Kim, J.S.; Kim, J.M.; Lee, J.Y.; Jung, H.C.; Song, I.S. Simvastatin induces apoptosis in human colon cancer cells and in tumor xenografts, and attenuates colitis-associated colon cancer in mice. Int. J. Cancer 2008, 123, 951-957.
62. Xiao, H.; Zhang, Q.; Lin, Y.; Reddy, B.S.; Yang, C.S. Combination of atorvastatin and celecoxib synergistically induces cell cycle arrest and apoptosis in colon cancer cells. Int. J. Cancer 2008, 122, 2115-2124.
63. Chan, K.K.; Oza, A.M.; Siu, L.L. The statins as anticancer agents. Clin. Cancer Res. 2003, 9, 10-19.
64. Sassano, A.; Platanias, L.C. Statins in tumor suppression. Cancer Lett. 2008, 260, 11-19.
65. Bardou, M.; Barkun, A.; Martel, M. Effect of statin therapy on colorectal cancer. Gut 2010, 59, 1572-1585.
66. Carrasco, S.; Mérida, I. Diacylglycerol, when simplicity becomes complex. Trends Biochem. Sci. 2007, 32, 27-36.
67. Decrock, E.; de Bock, M.; Wang, N.; Gadicherla, A.K.; Bol, M.; Delvaeye, T.; Vandenabeele, P.; Vinken, M.; Bultynck, G.; Krysko, D.V.; et al. IP3, a small molecule with a powerful message. Biochim. Biophys. Acta 2013, 1833, 1772-1786.
68. Zhang, Y.; Du, G. Phosphatidic acid signaling regulation of Ras superfamily of small guanosine triphosphatases. Biochim. Biophys. Acta 2009, 1791, 850-855.
69. Yang, C.Y.; Frohman, M.A. Mitochondria: Signaling with phosphatidic acid. Int. J. Biochem. Cell Biol. 2012, 44, 1346-1350.
70. Foster, D.A. Phosphatidic acid signaling to mTOR: Signals for the survival of human cancer cells. Biochim. Biophys. Acta 2009, 1791, 949-955.
71. Huang, C.; Bruggeman, L.A.; Hydo, L.M.; Miller, R.T. Shear stress induces cell apoptosis via a c-Src-phospholipase D-mTOR signaling pathway in cultured podocytes. Exp. Cell Res. 2012, 318, 1075-1785.
72. Mullen, T.D.; Obeid, L.M. Ceramide and apoptosis: Exploring the enigmatic connections between sphingolipid metabolism and programmed cell death. Anticancer Agents Med. Chem. 2012, 12, 340-363.
73. Obeid, L.M.; Linardic, C.M.; Karolak, L.A.; Hannun, Y.A. Programmed cell death induced by ceramide. Science 1993, 259, 1769-1771.
74. Kihara, A.; Mitsutake, S.; Mizutani, Y.; Igarashi, Y. Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate. Prog. Lipid Res. 2007, 46, 126-144.
75. Liu, Y.Y.; Hill, R.A.; Li, Y.T. Ceramide glycosylation catalyzed by glucosylceramide synthase and cancer drug resistance. Adv. Cancer Res. 2013, 117, 59-89.
76. Aranda, J.F.; Madrigal-Matute, J.; Rotllan, N.; Fernández-Hernando, C. MicroRNA modulation of lipid metabolism and oxidative stress in cardiometabolic diseases. Free Radic. Biol. Med. 2013, 64, 31-39.
77. Flowers, E.; Froelicher, E.S.; Aouizerat, B.E. MicroRNA regulation of lipid metabolism. Metabolism 2013, 62, 12-20.
78. Rottiers, V.; Näär, A.M. MicroRNAs in metabolism and metabolic disorders. Nat. Rev. Mol. Cell Biol. 2012, 13, 239-250.
79. Nie, Y.Q.; Cao, J.; Zhou, Y.J.; Liang, X.; Du, Y.L.; Wan, Y.J.; Li, Y.Y. The effect of miRNA-122 in regulating fat deposition in a cell line model. J. Cell. Biochem. 2014, 115, 839-846.
80. Tsai, W.C.; Hsu, S.D.; Hsu, C.S.; Lai, T.C.; Chen, S.J.; Shen, R.; Huang, Y.; Chen, H.C.; Lee, C.H.; Tsai, T.F.; et al. MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. J. Clin. Investig. 2012, 122, 2884-2897.
81. Esau, C.; Davis, S.; Murray, S.F.; Yu, X.X.; Pandey, S.K.; Pear, M.; Watts, L.; Booten, S.L.; Graham, M.; McKay, R.; et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab. 2006, 3, 87-98.
82. Krützfeldt, J.; Rajewsky, N.; Braich, R.; Rajeev, K.G.; Tuschl, T.; Manoharan, M.; Stoffel, M. Silencing of microRNAs in vivo with "antagomirs". Nature 2005, 438, 685-689.
83. Lanford, R.E.; Hildebrandt-Eriksen, E.S.; Petri, A.; Persson, R.; Lindow, M.; Munk, M.E.; Kauppinen, S.; Ørum, H. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 2010, 327, 198-201.
84. Najafi-Shoushtari, S.H.; Kristo, F.; Li, Y.; Shioda, T.; Cohen, D.E.; Gerszten, R.E.; Näär, A.M. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science 2010, 328, 1566-1569.
85. Marquart, T.J.; Allen, R.M.; Ory, D.S.; Baldán, A. miR-33 links SREBP-2 induction to repression of sterol transporters. Proc. Natl. Acad. Sci. USA 2010, 107, 12228-12232.
86. Rayner, K.J.; Suárez, Y.; Dávalos, A.; Parathath, S.; Fitzgerald, M.L.; Tamehiro, N.; Fisher, E.A.; Moore, K.J.; Fernández-Hernando, C. MiR-33 contributes to the regulation of cholesterol homeostasis. Science 2010, 328, 1570-1573.
87. Iliopoulos, D.; Drosatos, K.; Hiyama, Y.; Goldberg, I.J.; Zannis, V.I. MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolism. J. Lipid Res. 2010, 51, 1513-1523.
88. Gerin, I.; Bommer, G.T.; McCoin, C.S.; Sousa, K.M.; Krishnan, V.; MacDougald, O.A. Roles for miRNA-378/378 in adipocyte gene expression and lipogenesis. Am. J. Physiol. 2010, 299, E198-E206.
89. Kroemer, G.; Galluzzi, L.; Vandenabeele, P.; Abrams, J.; Alnemri, E.S.; Baehrecke, E.H.; Blagosklonny, M.V.; El-Deiry, W.S.; Golstein, P.; Green, D.R.; et al. Classification of cell death: Recom mendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ. 2009, 16, 3-11.
90. Fuchs, Y.; Steller, H. Programmed cell death in animal development and disease. Cell 2011, 147, 742-758.
91. Green, D.R.; Levine, B. To be or not to be? How selective autophagy and cell death govern cell fate. Cell 2014, 157, 65-75.
92. Nikoletopoulou, V.; Markaki, M.; Palikaras, K.; Tavernarakis, N. Crosstalk between apoptosis, necrosis and autophagy. Biochim. Biophys. Acta 2013, 1833, 3448-3459.
93. Christofferson, D.E.; Yuan, J. Necroptosis as an alternative form of programmed cell death. Curr. Opin. Cell Biol. 2010, 22, 263-268.
94. Golstein, P.; Kroemer, G. Cell death by necrosis: Towards a molecular definition. Trends Biochem. Sci. 2007, 32, 37-43.
95. Muñoz-Pinedo, C. Signaling pathways that regulate life and cell death: Evolution of apoptosis in the context of self-defense. Adv. Exp. Med. Biol. 2012, 738, 124-143.
96. Shimabukuro, M.; Zhou, Y.T.; Levi, M.; Unger, R.H. Fatty acid-induced beta cell apoptosis: A link between obesity and diabetes. Proc. Natl. Acad. Sci. USA 1998, 95, 2498-2502.
97. Karaskov, E.; Scott, C.; Zhang, L.; Teodoro, T.; Ravazzola, M.; Volchuk, A. Chronic palmitate but not oleate exposure induces endoplasmic reticulum stress, which may contribute to INS-1 pancreatic beta-cell apoptosis. Endocrinology 2006, 147, 3398-3407.
98. Kong, J.Y.; Rabkin, S.W. Palmitate-induced apoptosis in cardiomyocytes is mediated through alterations in mitochondria: Prevention by cyclosporin A. Biochim. Biophys. Acta 2000, 1485, 45-55.
99. Chai, W.; Liu, Z. p38 mitogen-activated protein kinase mediates palmitate-induced apoptosis but not inhibitor of nuclear factor-κB degradation in human coronary artery endothelial cells. Endocrinology 2007, 148, 1622-1628.
100. Malhi, H.; Gores, G.J. Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease. Semin. Liver Dis. 2008, 28, 360-309.
101. Kern, J.C.; Kehrer, J.P. Free radicals and apoptosis: Relationships with glutathione, thioredoxin and the Bcl family of proteins. Front. Biosci. 2005, 10, 1727-1738.
102. Dalleau, S.; Baradat, M.; Guéraud, F.; Huc, L. Cell death and diseases related to oxidative stress: 4-hydroxynonenal (HNE) in the balance. Cell Death Differ. 2013, 20, 1615-1630.
103. Elamin, E.E.; Masclee, A.A.; Dekker, J.; Pieters, H.J.; Jonkers, D.M. Short-chain fatty acids activate AMP-activated protein kinase and ameliorate ethanol-induced intestinal barrier dysfunction in Caco-2 cell monolayers. J. Nutr. 2013, 143, 1872-1881.
104. Bi, L.; Chiang, J.Y.; Ding, W.X.; Dunn, W.; Roberts, B.; Li, T. Saturated fatty acids activate ERK signaling to downregulate hepatic sortilin 1 in obese and diabetic mice. J. Lipid Res. 2013, 54, 2754-2762.
105. Kim, M.H.; Kang, S.G.; Park, J.H.; Yanagisawa, M.; Kim, C.H. Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice. Gastroenterology 2013, 145, 396-406.
106. Huang, S.; Rutkowsky, J.M.; Snodgrass, R.G.; Ono-Moore, K.D.; Schneider, D.A.; Newman, J.W.; Adams, S.H.; Hwang, D.H. Saturated fatty acids activate TLR-mediated proinflammatory signaling pathways. J. Lipid Res. 2012, 53, 2002-2013.
107. Holzer, R.G.; Park, E.J.; Li, N.; Tran, H.; Chen, M.; Choi, C.; Solinas, G.; Karin, M. Saturated fatty acids induce c-Src clustering within membrane subdomains, leading to JNK activation. Cell 2011, 147, 173-184.
108. Li, H.; Li, H.; Bao, Y.; Zhang, X.; Yu, Y. Free fatty acids induce endothelial dysfunction and activate protein kinase C and nuclear factor-κB pathway in rat aorta. Int. J. Cardiol. 2011, 152, 218-224.
109. Ibrahim, S.H.; Kohli, R.; Gores, G.J. Mechanisms of lipotoxicity in NAFLD and clinical implications. J. Pediatr. Gastroenterol. Nutr. 2011, 53, 131-140.
110. Awasthi, Y.C.; Sharma, R.; Sharma, A.; Yadav, S.; Singhal, S.S.; Chaudhary, P.; Awasthi, S. Self-regulatory role of 4-hydroxynonenal in signaling for stress-induced programmed cell death. Free Radic. Biol. Med. 2008, 45, 111-118.
111. Knauss, T.C.; Jaffer, F.E.; Abboud, H.E. Phosphatidic acid modulates DNA synthesis, phospholipase C, and platelet-derived growth factor mRNAs in cultured mesangial cells. Role of protein kinase C. J. Biol. Chem. 1990, 265, 14457-14463.
112. Moolenaar, W.H.; Kruijer, W.; Tilly, B.C.; Verlaan, I.; Bierman, A.J.; de Laat, S.W. Growth factor-like action of phosphatidic acid. Nature 1986, 323, 171-173.
113. Agwu, D.E.; McPhail, L.C.; Sozzani, S.; Bass, D.A.; McCall, C.E. Phosphatidic acid as a second messenger in human polymorphonuclear leukocytes. Effects on activation of NADPH oxidase. J. Clin. Investig. 1991, 88, 531-539.
114. Yang, S.; Lu, S.H.; Yuan, Y.J. Cerium elicitor-induced phosphatidic acid triggers apoptotic signaling development in Taxus cuspidata cell suspension cultures. Chem. Phys. Lipids 2009, 159, 13-20.
115. Zhao, K.; Zhou, H.; Zhao, X.; Wolff, D.W.; Tu, Y.; Liu, H.; Wei, T.; Yang, F. Phosphatidic acid mediates the targeting of tBid to induce lysosomal membrane permeabilization and apoptosis. J. Lipid Res. 2012, 53, 2102-2114.
116. Norambuena, A.; Metz, C.; Vicuña, L.; Silva, A.; Pardo, E.; Oyanadel, C.; Massardo, L.; González, A.; Soza, A. Galectin-8 induces apoptosis in Jurkat T cells by phosphatidic acid-mediated ERK1/2 activation supported by protein kinase A down-regulation. J. Biol. Chem. 2009, 284, 12670-12679.
117. Saddoughi, S.A.; Ogretmen, B. Diverse functions of ceramide in cancer cell death and proliferation. Adv. Cancer Res. 2013, 117, 37-58.
118. Uchida, Y. Ceramide signaling in mammalian epidermis. Biochim. Biophys. Acta 2014, 1841, 453-462.
119. Chalfant, C.E.; Szulc, Z.; Roddy, P.; Bielawska, A.; Hannun, Y.A. The structural requirements for ceramide activation of serine-threonine protein phosphatases. J. Lipid Res. 2004, 45, 496-506.
120. Lozano, J.; Berra, E.; Municio, M.M.; Diaz-Meco, M.T.; Dominguez, I.; Sanz, L.; Moscat, J. Protein kinase C zeta isoformis critical for kappa B-dependent promoter activation by sphingomyelinase. J. Biol. Chem. 1994, 269, 19200-19202.
121. Heinrich, M.; Wickel, M.; Schneider-Brachert, W.; Sandberg, C.; Gahr, J.; Schwandner, R.; Weber, T.; Saftig, P.; Peters, C.J.; Brunner, J.; et al. Cathepsin D targeted by acid sphingomyelinase-derived ceramide. EMBO J. 1999, 18, 5252-5263.
122. Zhang, Y.; Yao, B.; Delikat, S.; Bayoumy, S.; Lin, X.H.; Basu, S.; McGinley, M.; Chan-Hui, P.-Y.; Lichenstein, H.; Kolesnick, R.; et al. Kinase suppressor of Ras is ceramide-activated protein kinase. Cell 1997, 89, 63-72.
123. Colombini, M. Membrane channels formed by ceramide. Handb. Exp. Pharmacol. 2013, 2013, 109-126.
124. Siskind, L.J.; Kolesnick, R.N.; Colombini, M. Ceramide channels increase the permeability of the mitochondrial outer membrane to small proteins. J. Biol. Chem. 2002, 277, 26796-26803.
125. Sottero, B.; Gamba, P.; Gargiulo, S.; Leonarduzzi, G.; Poli, G. Cholesterol oxidation products and disease: An emerging topic of interest in medicinal chemistry. Curr. Med. Chem. 2009, 16, 685-705.
126. Schroepfer, G.J., Jr. Oxysterols: Modulators of cholesterol metabolism and other processes. Physiol. Rev. 2000, 80, 361-554.
127. Colell, A.; Fernández, A.; Fernández-Checa, J.C. Mitochondria, cholesterol and amyloid beta peptide: A dangerous trio in Alzheimer disease. J. Bioenerg. Biomembr. 2009, 41, 417-423.
128. De Medina, P.; Paillasse, M.R.; Segala, G.; Voisin, M.; Mhamdi, L.; Dalenc, F.; Lacroix-Triki, M.; Filleron, T.; Pont, F.; Saati, T.A.; et al. Dendrogenin A arises from cholesterol and histamine metabolism and shows cell differentiation and anti-tumour properties. Nat. Commun. 2013, 4, 1840.
129. Segala, G.; de Medina, P.; Iuliano, L.; Zerbinati, C.; Paillasse, M.R.; Noguer, E.; Dalenc, F.; Payré, B.; Jordan, V.C.; Record, M.; et al. 5,6-Epoxy-cholesterols contribute to the anticancer pharmacology of tamoxifen in breast cancer cells. Biochem. Pharmacol. 2013, 86, 175-189.
130. Wan, G.; Zhaorigetu, S.; Liu, Z.; Kaini, R.; Jiang, Z.; Hu, C.A. Apolipoprotein L1, a novel Bcl-2 homology domain 3-only lipid-binding protein, induces autophagic cell death. J. Biol. Chem. 2008, 283, 21540-21549.
131. Liu, Z.; Lu, H.; Jiang, Z.; Pastuszyn, A.; Hu, C.A. Apolipoprotein L6, a novel proapoptotic Bcl-2 homology 3-only protein, induces mitochondria-mediated apoptosis in cancer cells. Mol. Cancer Res. 2005, 3, 21-31.
132. Quinn, C.M.; Kågedal, K.; Terman, A.; Stroikin, U.; Brunk, U.T.; Jessup, W.; Garner, B. Induction of fibroblast apolipoprotein E expression during apoptosis, starvation-induced growth arrest and mitosis. Biochem. J. 2004, 378, 753-761.
133. Mahley, R.W.; Huang, Y. Apolipoprotein e sets the stage: Response to injury triggers neuropathology. Neuron 2012, 76, 871-885.
134. Salvayre, R.; Auge, N.; Benoist, H.; Negre-Salvayre, A. Oxidized low-density lipoprotein-induced apoptosis. Biochim. Biophys. Acta 2002, 1585, 213-221.
135. Mattson, M.P.; Chan, S.L. Calcium orchestrates apoptosis. Nat. Cell Biol. 2003, 5, 1041-1043.
136. Garcia-Prieto, C.; Riaz Ahmed, K.B.; Chen, Z.; Zhou, Y.; Hammoudi, N.; Kang, Y.; Lou, C.; Mei, Y.; Jin, Z.; Huang, P.; et al. Effective killing of leukemia cells by the natural product OSW-1 through disruption of cellular calcium homeostasis. J. Biol. Chem. 2013, 288, 3240-3250.
137. Kiviluoto, S.; Vervliet, T.; Ivanova, H.; Decuypere, J.P.; de Smedt, H.; Missiaen, L.; Bultynck, G.; Parys, J.B. Regulation of inositol 1,4,5-trisphosphate receptors during endoplasmic reticulum stress. Biochim. Biophys. Acta 2013, 1833, 1612-1624.
138. Murgia, M.; Giorgi, C.; Pinton, P.; Rizzuto, R. Controlling metabolism and cell death: At the heart of mitochondrial calcium signalling. J. Mol. Cell. Cardiol. 2009, 46, 781-788.
139. 2+ handling systems in differentiating PC12 cells. Cell. Calcium 2012, 52, 433-444.
140. Van Vliet, A.R.; Verfaillie, T.; Agostinis, P. New functions of mitochondria associated membranes in cellular signaling. Biochim. Biophys. Acta 2014, 1843, 2253-2262.
141. Hayashi, T.; Rizzuto, R.; Hajnoczky, G.; Su, T.P. MAM: More than just a housekeeper. Trends Cell Biol. 2009, 19, 81-88.
142. Grimm, S. The ER-mitochondria interface: The social network of cell death. Biochim. Biophys. Acta 2012, 1823, 327-334.
143. Marchi, S.; Patergnani, S.; Pinton, P. The endoplasmic reticulum-mitochondria connection: One touch, multiple functions. Biochim. Biophys. Acta 2014, 1837, 461-469.
144. Raturi, A.; Simmen, T. Where the endoplasmic reticulum and the mitochondrion tie the knot: The mitochondria-associated membrane (MAM). Biochim. Biophys. Acta 2013, 1833, 213-224.
145. Vance, J.E. MAM (mitochondria-associated membranes) in mammalian cells: Lipids and beyond. Biochim. Biophys. Acta 2014, 1841, 595-609.
146. Ardail, D.; Popa, I.; Bodennec, J.; Louisot, P.; Schmitt, D.; Portoukalian, J. The mitochondriaassociated endoplasmic-reticulum subcompartment (MAM fraction) of rat liver contains highly active sphingolipid-specific glycosyltransferases. Biochem. J. 2003, 371, 1013-1019.
147. Lupu, R.; Menendez, J.A. Pharmacological inhibitors of Fatty Acid Synthase (FASN) catalyzed endogenous fatty acid biogenesis: A new family of anti-cancer agents? Curr. Pharm. Biotechnol. 2006, 7, 483-493.
148. Janardhan, S.; Srivani, P.; Sastry, G.N. Choline kinase: An important target for cancer. Curr. Med. Chem. 2006, 13, 1169-1186.
149. Danilo, C.; Frank, P.G. Cholesterol and breast cancer development. Curr. Opin. Pharmacol. 2012, 12, 677-682.
150. Wenk, M.R. The emerging field of lipidomics. Nat. Rev. Drug Discov. 2005, 4, 594-610.
151. Postle, A.D. Lipidomics. Curr. Opin. Clin. Nutr. Metab. Care 2012, 15, 127-133.
152. Senchenkov, A.; Litvak, D.A.; Cabot, M.C. Targeting ceramide metabolism-A strategy for overcoming drug resistance. J. Natl. Cancer Inst. 2001, 93, 347-357.
153. Kridel, S.J.; Lowther, W.T.; Pemble, C.W. 4th Fatty acid synthase inhibitors: New directions for oncology. Expert Opin. Investig. Drugs 2007, 16, 1817-1829.
154. 2-X and COX-2. Anticancer Res. 2007, 27, 1493-1502.
155. Menendez, J.A.; Lupu, R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat. Rev. Cancer 2007, 7, 763-777.
156. Benakanakere, I.; Johnson, T.; Sleightholm, R.; Villeda, V.; Arya, M.; Bobba, R.; Freter, C.; Huang, C. Targeting cholesterol synthesis increases chemoimmuno-sensitivity in chronic lymphocytic leukemia cells. Exp. Hematol. Oncol. 2014, 3, 24.
157. Kotas, M.E.; Jurczak, M.J.; Annicelli, C.; Gillum, M.P.; Cline, W.; Shulman, G.I.; Medzhitov, R. Role of caspase-1 in regulation of triglyceride metabolism. Proc. Natl. Acad. Sci. USA 2013, 110, 4810-4815.
158. Schilling, T.; Eder, C. Sodium dependence of lysophosphatidylcholine-induced caspase-1 activity and reactive oxygen species generation. Immunobiology 2011, 216, 118-125.
159. Schumann, R.R.; Belka, C.; Reuter, D.; Lamping, N.; Kirschning, C.J.; Weber, J.R.; Pfeil, D. Lipopolysaccharide activates caspase-1 (interleukin-1-converting enzyme) in cultured monocytic and endothelial cells. Blood 1998, 91, 577-584.
160. Schroeder, G.N.; Hilbi, H. Cholesterol is required to trigger caspase-1 activation and macrophage apoptosis after phagosomal escape of Shigella. Cell. Microbiol. 2007, 9, 265-278.
161. Galluzzi, L.; Kepp, O.; Kroemer, G. Caspase-3 and prostaglandins signal for tumor regrowth in cancer therapy. Oncogene 2012, 31, 2805-2808.
162. Němcová-Fürstová, V.; James, R.F.; Kovář, J. Inhibitory effect of unsaturated fatty acids on saturated fatty acid-induced apoptosis in human pancreatic β-cells: Activation of caspases and ER stress induction. Cell. Physiol. Biochem. 2011, 27, 525-538.
163. Gonzalvez, F.; Schug, Z.T.; Houtkooper, R.H.; MacKenzie, E.D.; Brooks, D.G.; Wanders, R.J.; Petit, P.X.; Vaz, F.M.; Gottlieb, E. Cardiolipin provides an essential activating platform for caspase-8 on mitochondria. J. Cell Biol. 2008, 183, 681-696.
164. Luthra, S.; Dong, J.; Gramajo, A.L.; Chwa, M.; Kim, D.W.; Neekhra, A.; Kuppermann, B.D.; Kenney, M.C. 7-Ketocholesterol activates caspases-3/7, -8, and -12 in human microvascular endothelial cells in vitro. Microvasc. Res. 2008, 75, 343-350.
165. Wu, B.; Iwakiri, R.; Ootani, A.; Fujise, T.; Tsunada, S.; Fujimoto, K. Platelet-activating factor promotes mucosal apoptosis via FasL-mediating caspase-9 active pathway in rat small intestine after ischemia-reperfusion. FASEB J. 2003, 17, 1156-1158.
166. Jiang, Y.J.; Kim, P.; Uchida, Y.; Elias, P.M.; Bikle, D.D.; Grunfeld, C.; Feingold, K.R. Ceramides stimulate caspase-14 expression in human keratinocytes. Exp. Dermatol. 2013, 22, 113-118.
167. Lippens, S.; Kockx, M.; Denecker, G.; Knaapen, M.; Verheyen, A.; Christiaen, R.; Tschachler, E.; Vandenabeele, P.; Declercq, W. Vitamin D3 induces caspase-14 expression in psoriatic lesions and enhances caspase-14 processing in organotypic skin cultures. Am. J. Pathol. 2004, 165, 833-841.
168. Edelmann, B.; Bertsch, U.; Tchikov, V.; Winoto-Morbach, S.; Perrotta, C.; Jakob, M.; Adam-Klages, S.; Kabelitz, D.; Schütze, S. Caspase-8 and caspase-7 sequentially mediate proteolytic activation of acid sphingomyelinase in TNF-R1 receptosomes. EMBO J. 2011, 30, 379-394.
169. Lafont, E.; Dupont, R.; Andrieu-Abadie, N.; Okazaki, T.; Schulze-Osthoff, K.; Levade, T.; Benoist, H.; Ségui, B. Ordering of ceramide formation and caspase-9 activation in CD95L-induced Jurkat leukemia T cell apoptosis. Biochim. Biophys. Acta 2012, 1821, 684-693.
170. Heinrich, M.; Neumeyer, J.; Jakob, M.; Hallas, C.; Tchikov, V.; Winoto-Morbach, S.; Wickel, M.; Schneider-Brachert, W.; Trauzold, A.; Hethke, A.; et al. Cathepsin D links TNF-induced acid sphingomyelinase to Bid-mediated caspase-9 and -3 activation. Cell Death Differ. 2004, 11, 550-563.
171. Zhu, Q.; Lin, L.; Cheng, Q.; Xu, Q.; Zhang, J.; Tomlinson, S.; Jin, J.; Chen, X.; He, S. The role of acid sphingomyelinase and caspase 5 in hypoxia-induced HuR cleavage and subsequent apoptosis in hepatocytes. Biochim. Biophys. Acta 2012, 1821, 1453-1461.
172. Siegel, R.; Naishadham, D.; Jemal, A. Cancer statistics, 2013. CA Cancer J. Clin. 2013, 63, 11-30.
173. Datta, S.C.; Radin, N.S. Stimulation of liver growth and DNA synthesis by glucosylceramide. Lipids 1988, 23, 508-510.